Arkolith/Insider Trading/HURA/Form 4

Bianco James A.

Chief Executive Officer, DirectorTuHURA Biosciences, Inc./NV (HURA) · full profile →Form 4 · filed Dec 17, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 12, 2025Grant(A)3.4M—$03.4M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000897069-25-001807) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML